Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: "Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)." Schaeverbeke et al. Joint Bone Spine 2018;95:399-402

Affiliations

¹ Rheumatology department, Lapeyronie hospital, Montpellier university hospital center, 34295 Montpellier Cedex 5, France. Electronic address: jd-cohen@chu-montpellier.fr.
² French national patient organization against rheumatoid arthritis (ANDAR), 75014 Paris, France.
³ BioCube institute, groupe IMT, 37000 Tours, France.
⁴ Law and health economics department, faculty of pharmacy, Paris Descartes university, Sorbonne Paris Cité, 4, avenue de l'Observatoire, 75006 Paris, France; Health law institute (Inserm UMR S1145), Paris Descartes university, Sorbonne Paris Cité, 45, rue des Saints-Pères, 75006 Paris, France; Pharmacy department, general agency of equipments and health products (AGEPS), 7, rue du Fer à Moulin, 75005 Paris, France.

Comment

Jean-David Cohen et al. Joint Bone Spine. 2019 Mar.

. 2019 Mar;86(2):287-288.

doi: 10.1016/j.jbspin.2018.10.009. Epub 2018 Oct 27.

¹ Rheumatology department, Lapeyronie hospital, Montpellier university hospital center, 34295 Montpellier Cedex 5, France. Electronic address: jd-cohen@chu-montpellier.fr.
² French national patient organization against rheumatoid arthritis (ANDAR), 75014 Paris, France.
³ BioCube institute, groupe IMT, 37000 Tours, France.
⁴ Law and health economics department, faculty of pharmacy, Paris Descartes university, Sorbonne Paris Cité, 4, avenue de l'Observatoire, 75006 Paris, France; Health law institute (Inserm UMR S1145), Paris Descartes university, Sorbonne Paris Cité, 45, rue des Saints-Pères, 75006 Paris, France; Pharmacy department, general agency of equipments and health products (AGEPS), 7, rue du Fer à Moulin, 75005 Paris, France.

No abstract available

Keywords: Biosimilars; Extrapolation; Interchanggeability; Nocebo; Rheumatology; Shared decision making.

Comment on

Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI).
Schaeverbeke T, Pham T, Richez C, Wendling D. Schaeverbeke T, et al. Joint Bone Spine. 2018 Jul;85(4):399-402. doi: 10.1016/j.jbspin.2018.03.002. Epub 2018 Mar 21. Joint Bone Spine. 2018. PMID: 29574143 No abstract available.